Document Detail

Salvage of a congested DIEAP flap with subcutaneous recombinant tissue plasminogen activator treatment.
MedLine Citation:
PMID:  18851936     Owner:  NLM     Status:  MEDLINE    
Thrombolytic agents are frequently employed in the treatment of thrombosis in combination with early surgical exploration and management. Recombinant tissue plasminogen activator is a second generation thrombolytic agent, which acts specifically at the site of the haemostatic clot with minimal side effects. In this paper, we present a case with venous congestion of the deep inferior epigastric artery perforator (DIEAP) flap, despite a patent anastomosis, in which we achieved a successful outcome with subcutaneous recombinant tissue plasminogen activator treatment.
Suhan Ayhan; Safak Uygur; Ismail Kucukoduk; Ayse Sencan
Related Documents :
21980206 - Risk profile of intracranial aneurysms: rupture rate is not constant after formation.
21907356 - Endovascular versus open repair of ruptured descending thoracic aortic aneurysms: a nat...
7568476 - The arterial basis of pharyngeal flaps.
14758206 - Arterial anatomical features of the upper palpebra.
7154186 - Dissolution of cystine calculi by pelviocaliceal irrigation with tromethamine-e.
16820386 - Relationship between carotid intima-media thickness and arterial stiffness in children ...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2008-10-11
Journal Detail:
Title:  Journal of plastic, reconstructive & aesthetic surgery : JPRAS     Volume:  62     ISSN:  1878-0539     ISO Abbreviation:  J Plast Reconstr Aesthet Surg     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2010-01-19     Completed Date:  2010-02-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264239     Medline TA:  J Plast Reconstr Aesthet Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  e453-4     Citation Subset:  IM    
Copyright Information:
(c) 2008 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Gazi University, Faculty of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Breast Neoplasms / pathology,  surgery
Epigastric Arteries*
Fibrinolytic Agents / therapeutic use*
Follow-Up Studies
Graft Survival
Injections, Subcutaneous
Mammaplasty / adverse effects*,  methods
Mastectomy / methods
Middle Aged
Postoperative Complications / diagnosis,  drug therapy
Rectus Abdominis / blood supply,  transplantation
Risk Assessment
Salvage Therapy
Surgical Flaps / blood supply*
Thrombosis / drug therapy*,  etiology
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome
Reg. No./Substance:
0/Fibrinolytic Agents; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The radial forearm free flap: a review of microsurgical options.
Next Document:  The first intermediate host of Paragonimus westermani in Sri Lanka.